Orthofix Medical Inc. Gain (Loss) Related to Litigation Settlement
Orthofix Medical Inc. (OFIX) reported Gain (Loss) Related to Litigation Settlement of $2.19 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2026-08-05
- Orthofix Medical Inc. gain (loss) related to litigation settlement for the quarter ending 2026-06-30 was $2.19M, a 45.77% decline year-over-year.
- Orthofix Medical Inc. gain (loss) related to litigation settlement for the quarter ending 2026-03-31 was $2.92M, a 4.14% decline year-over-year.
- Orthofix Medical Inc. gain (loss) related to litigation settlement for the quarter ending 2025-12-31 was -$62.41M.
- Orthofix Medical Inc. gain (loss) related to litigation settlement for the quarter ending 2025-09-30 was $21.55M, a 158.52% increase year-over-year.
- Orthofix Medical Inc. gain (loss) related to litigation settlement for fiscal 2025 was -$33.79M.
- Orthofix Medical Inc. gain (loss) related to litigation settlement for fiscal 2024 was -$15.77M.
- Orthofix Medical Inc. gain (loss) related to litigation settlement for fiscal 2023 was -$14.45M.
- Orthofix Medical Inc. gain (loss) related to litigation settlement for fiscal 2022 was -$803.00K.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 3 month as first filed | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 6 month as first filed | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 9 month as first filed | Gain (Loss) Related to Litigation Settlement 12 month | Gain (Loss) Related to Litigation Settlement 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.19M 10-Q · filed 2026-08-05 | $5.10M 10-Q · filed 2026-08-05 | -$57.31M derived: sum of 3 quarters · filed 2026-08-05 | -$35.76M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $2.92M 10-Q · filed 2026-05-05 | -$59.49M derived: sum of 2 quarters · filed 2026-05-05 | -$37.94M derived: sum of 3 quarters · filed 2026-05-05 | -$33.91M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$62.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$40.86M derived: sum of 2 quarters · filed 2026-02-24 | -$36.83M derived: sum of 3 quarters · filed 2026-08-05 | -$33.79M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $21.55M 10-Q · filed 2025-11-04 | $25.58M derived: sum of 2 quarters · filed 2026-08-05 | $28.62M 10-Q · filed 2025-11-04 | $2.53M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $4.03M 10-Q · filed 2026-08-05 | $7.07M 10-Q · filed 2026-08-05 | -$19.02M derived: sum of 3 quarters · filed 2026-08-05 | -$10.68M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $3.04M 10-Q · filed 2026-05-05 | -$23.05M derived: sum of 2 quarters · filed 2026-05-05 | -$14.71M derived: sum of 3 quarters · filed 2026-05-05 | -$14.99M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$26.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$17.75M derived: sum of 2 quarters · filed 2026-02-24 | -$18.03M derived: sum of 3 quarters · filed 2026-02-24 | -$15.77M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $8.34M 10-Q · filed 2025-11-04 | $8.06M derived: sum of 2 quarters · filed 2025-11-04 | $10.32M 10-Q · filed 2025-11-04 | -$9.75M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | -$277.00K 10-Q · filed 2025-08-05 | $1.98M 10-Q · filed 2025-08-05 | -$18.08M derived: sum of 3 quarters · filed 2026-02-24 | -$14.23M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $2.26M 10-Q · filed 2025-05-06 | -$17.80M derived: sum of 2 quarters · filed 2026-02-24 | -$13.95M derived: sum of 3 quarters · filed 2026-02-24 | -$12.66M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | -$20.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$16.21M derived: sum of 2 quarters · filed 2026-02-24 | -$14.92M derived: sum of 3 quarters · filed 2026-02-24 | -$14.45M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $3.85M 10-Q · filed 2024-11-07 | $5.14M derived: sum of 2 quarters · filed 2024-11-07 | $5.61M 10-Q · filed 2024-11-07 | |||||
| 2023-06-30 | $1.29M 10-Q · filed 2024-08-06 | $1.76M 10-Q · filed 2024-08-06 | ||||||
| 2023-03-31 | $469.00K 10-Q · filed 2024-05-07 | |||||||
| 2022-12-31 | -$803.00K 10-K · filed 2025-02-25 | |||||||
| 2021-12-31 | -$33.00K 10-K · filed 2024-03-05 | |||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | -$1.50M derived: sum of 2 quarters · filed 2019-02-25 | -$14.37M derived: sum of 3 quarters · filed 2019-02-25 | -$14.37M 10-K · filed 2019-02-25 | ||||
| 2016-09-30 | -$1.50M 10-Q · filed 2017-10-30 | -$14.37M derived: sum of 2 quarters · filed 2017-10-30 | -$14.37M 10-Q · filed 2017-10-30 | |||||
| 2016-06-30 | -$12.87M 10-Q · filed 2017-08-07 | -$12.87M 10-Q · filed 2017-08-07 | ||||||
| 2015-09-30 | -$300.00K 10-Q · filed 2015-11-03 | |||||||
| 2014-12-31 | -$3.80M 10-Q · filed 2015-11-03 | |||||||
| 2013-12-31 | -$6.70M 10-Q · filed 2015-08-04 | |||||||
| 2012-12-31 | -$236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-29 | -$609.00K derived: sum of 2 quarters · filed 2015-04-29 | -$985.00K derived: sum of 3 quarters · filed 2015-04-29 | -$1.29M 10-K · filed 2015-04-29 | -$1.97M 10-K · filed 2013-03-01 | |||
| 2012-09-30 | -$373.00K 10-Q · filed 2014-03-25 | -$326.00K 10-Q · filed 2012-11-02 | -$749.00K derived: sum of 2 quarters · filed 2014-03-25 | -$1.06M 10-Q · filed 2014-03-25 | -$1.69M 10-Q · filed 2012-11-02 | -$12.20M derived: sum of 4 quarters · filed 2015-03-31 | ||
| 2012-06-30 | -$376.00K 10-Q · filed 2014-03-24 | -$1.36M 10-Q · filed 2012-07-30 | -$686.00K 10-Q · filed 2014-03-24 | -$1.36M 10-Q · filed 2012-07-30 | -$11.83M derived: sum of 3 quarters · filed 2015-03-31 | -$11.83M derived: sum of 4 quarters · filed 2015-03-31 | ||
| 2012-03-31 | -$310.00K 10-Q/A · filed 2014-03-24 | -$11.45M derived: sum of 2 quarters · filed 2015-03-31 | -$11.45M derived: sum of 3 quarters · filed 2015-03-31 | -$11.45M derived: sum of 4 quarters · filed 2015-03-31 | ||||
| 2011-12-31 | -$11.14M derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-03-31 | -$11.14M derived: sum of 2 quarters · filed 2015-03-31 | -$11.14M derived: sum of 3 quarters · filed 2015-03-31 | -$57.14M 10-K/A · filed 2015-03-31 | -$56.46M 10-K · filed 2012-02-29 | |||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $0.00 derived: sum of 2 quarters · filed 2012-11-02 | -$46.00M 10-Q · filed 2012-11-02 | |||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | -$46.00M 10-Q · filed 2012-07-30 | ||||||
| 2011-03-31 | -$46.00M 10-Q · filed 2012-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |